We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+263.17%
AUM
$2.95B
AUM Growth
+$144M
Cap. Flow
-$515M
Cap. Flow %
-17.44%
Top 10 Hldgs %
12.11%
Holding
468
New
29
Increased
98
Reduced
108
Closed
35

Top Buys

Rank Stock Value
1
NGVT icon
Ingevity
NGVT
+$12.5M
2
BEAT
BioTelemetry, Inc.
BEAT
+$9.4M
3
AABA
Altaba Inc
AABA
+$8.97M
4
V icon
Visa
V
+$8.04M
5
AME icon
Ametek
AME
+$6.96M

Top Sells

Rank Stock Value
1
SIVB
SVB Financial Group
SIVB
+$21.4M
2
OHI icon
Omega Healthcare
OHI
+$12.2M
3
RJF icon
Raymond James Financial
RJF
+$10.6M
4
PTC icon
PTC
PTC
+$10.6M
5
SMTC icon
Semtech
SMTC
+$10.5M

Sector Composition

Rank Sector Weight
1 Technology 12.71%
2 Financials 12.64%
3 Industrials 11.22%
4 Healthcare 9.34%
5 Consumer Discretionary 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRL
126
DELISTED
Control4 Corporation
CTRL
$6.13M 0.21%
205,946
-57,177
-22% -$1.77M
CVX icon
127
Chevron
CVX
$392B
$6.1M 0.21%
48,754
+11,879
+32% +$1.41M
RDS.A
128
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$6.04M 0.2%
90,495
+7,309
+9% +$461K
NVO
129
Novo Nordisk
NVO
$208B
$5.7M 0.19%
212,350
-1,000
-0.5% -$25.4K
TMO icon
130
Thermo Fisher Scientific
TMO
$213B
$5.66M 0.19%
29,827
-225
-0.7% -$43.1K
DD icon
131
DuPont de Nemours
DD
$18.5B
$5.57M 0.19%
30,900
+155
+0.5% +$27.9K
TMUS icon
132
T-Mobile US
TMUS
$185B
$5.4M 0.18%
+85,009
New +$5.19M
HON icon
133
Honeywell
HON
$77B
$5.38M 0.18%
38,868
+1,506
+4% +$202K
META icon
134
Meta Platforms (Facebook)
META
$1.42T
$5.26M 0.18%
29,825
+705
+2% +$125K
GPT
135
DELISTED
Gramercy Property Trust
GPT
$5.11M 0.17%
191,822
+19,672
+11% +$571K
FNF icon
136
Fidelity National Financial
FNF
$13.9B
$4.74M 0.16%
125,684
-48,388
-28% -$1.76M
LAZ icon
137
Lazard
LAZ
$4.13B
$4.74M 0.16%
90,253
-873
-1% -$41.8K
MCD icon
138
McDonald's
MCD
$192B
$4.74M 0.16%
27,521
MDLZ icon
139
Mondelez International
MDLZ
$79.5B
$4.7M 0.16%
109,898
-31,485
-22% -$1.32M
DPLO
140
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$4.59M 0.16%
+228,671
New +$4.5M
T icon
141
AT&T
T
$159B
$4.38M 0.15%
148,983
+16,748
+13% +$457K
WELL.PRI
142
DELISTED
Welltower Inc.
WELL.PRI
$4.17M 0.14%
68,984
+10,150
+17% +$628K
KDP icon
143
Keurig Dr Pepper
KDP
$42.3B
$3.86M 0.13%
39,737
+2,089
+6% +$187K
CCI.PRA
144
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$3.85M 0.13%
3,400
ROP icon
145
Roper Technologies
ROP
$38.8B
$3.77M 0.13%
14,555
+77
+0.5% +$19.8K
QCOM icon
146
Qualcomm
QCOM
$155B
$3.72M 0.13%
58,150
+100
+0.2% +$6.06K
ABBV icon
147
AbbVie
ABBV
$443B
$3.72M 0.13%
38,465
+150
+0.4% +$14.1K
SWP
148
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
$3.69M 0.12%
30,000
EPR.PRE icon
149
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$113M
$3.59M 0.12%
98,800
-1,300
-1% -$47K
BRK.A icon
150
Berkshire Hathaway Class A
BRK.A
$1.1T
$3.57M 0.12%
12

Similar funds

Palisade Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Palisade Capital Management held 468 positions worth $2.95B, up 5.1% from $2.81B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Palisade Capital Management withdrew a net $515M in Q4 2017, closing 35 positions and reducing 108 holdings. Its most notable exit was Omega Healthcare, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Palisade Capital Management opened a new position in Ingevity worth $12.2M.

  • Palisade Capital Management's largest Q4 2017 buy was Ingevity: 172,880 shares worth $12.2M.
  • Palisade Capital Management added most to Visa in Q4 2017, an estimated $8.04M increase.
  • Palisade Capital Management's biggest Q4 2017 reduction was SVB Financial Group, cutting an estimated $21.4M.
  • Palisade Capital Management fully exited Omega Healthcare in Q4 2017, selling an estimated $12.2M.
  • Palisade Capital Management's ten largest holdings make up 12% of its $2.95B portfolio in Q4 2017.
  • Palisade Capital Management opened 29 new positions and closed 35 in Q4 2017.
  • Palisade Capital Management's portfolio value rose 5.1% quarter-over-quarter to $2.95B.

Based on Palisade Capital Management's 13F filing for Q4 2017, filed 9 Feb 2018.